Skip to main content

Table 2 Detection of galectin-9 in liver specimens from infected (HCV, HBV) or non-infected patients

From: A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses

Patient

Gender/Age Medical History

Viral diagnosis

Histological diagnosis

Galectin-9 staining

    

Leucocytes or related cells

Hepatocytes

1

M/54

Chronic HCV infection

HCV cirrhosis with transformed foci

-

+ +

 

Alcoholism

    

2

M/66

Chronic HCV infection

Micronodular cirrhosis associated to a carcinoma

+ + (aspect of Kupffer cells)

+ +

 

Alcoholism

    

3

M/61

Chronic HCV infection

Micronodular cirrhosis with transformed foci

+

+

4

M/67

Chronic HBV infection

Macronodular cirrhosis associated to a carcinoma

+

+

5

M/50

Chronic HBV infection

Hepatic fibrosis associated to a carcinoma

+ +

+ +

6

M/30

Chronic HBV infection

Liver tissue with minimal lesions next to a non-malignant nodule (focal nodular hyperplasia)

+

+ +

7

F/32

No infection

Normal liver tissue next to a non-malignant nodule (focal nodular hyperplasia)

-

-

8

F/20

No infection

Normal liver tissue next to an adenoma

-

-

9

F/28

No infection

Normal liver tissue next to an adenoma (with steatosis)

-

-

  1. ++ : homogeneous galectin-9 staining, + : mild or scattered galectin-9 staining, - : absence of galectin-9 staining.